Loading...
Market
Which pharmaceutical company will announce an increase in dexamethasone production first by January 4, 2025?
3
Resolution / Starting Odds
Pfizer • 25%
AstraZeneca • 25%
Roche • 25%
Other • 25%
Official announcements from pharmaceutical companies
Story
Dexamethasone's Life-Saving Effect in Severe COVID-19 Linked to Monocyte Dysregulation Reversal, Cell Press Study
Jul 4, 2024, 08:32 AM
Scientists have uncovered the life-saving effects of dexamethasone in severe COVID-19 cases, linked to the reversal of monocyte dysregulation. This discovery was detailed in a study published by Cell Press on July 3 and July 4, which identified dexamethasone-specific immune signatures in the blood and lungs of patients. The study highlights that dexamethasone-induced transcriptional changes are confined to a specific monocyte state, directly linking molecular responses in monocytes to clinical outcomes. The research was a collaborative effort involving teams from DZNE, AschenbrennerAC, LabSchultze, KurthGroup, and Sander_Lab.
View original story
Similar markets
Novo Nordisk • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Other • 25%
Novo Nordisk • 25%
Sanofi • 25%
Merck • 25%
Other • 25%
Johnson & Johnson • 25%
Merck • 25%
AstraZeneca • 25%
Other • 25%
Yes • 50%
No • 50%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
Pfizer • 25%
Moderna • 25%
AstraZeneca • 25%
Johnson & Johnson • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Merck & Co. • 25%
Other • 25%
Yes • 50%
No • 50%
Novo Nordisk • 25%
Sanofi • 25%
Eli Lilly • 25%
Other • 25%
Moderna • 25%
Pfizer • 25%
AstraZeneca • 25%
Other • 25%
Pfizer • 25%
Merck • 25%
Johnson & Johnson • 25%
Other • 25%
Pfizer • 25%
Merck • 25%
Johnson & Johnson • 25%
Other • 25%